"Special treatment": BiDil, Tuskegee, and the logic of race.

Abstract

BiDil, a drug approved in 2005 by the FDA only for African Americans, was seen by many as almost reparations for the horrors of the Tuskegee Syphilis Study (1932-72) where treatment for black men was denied. The logic of race, however, rather than racism, links BiDil to the past many thought it was escaping.

• Authors: Susan M Reverby
• Journal: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics (J Law Med Ethics) Vol. 36 Issue 3 Pg. 478-84 ( 2008) ISSN: 1073-1105 [Print] England
• PMID: 18840239 (Publication Type: Journal Article)

Chemical References

• Drug Combinations
• Vasodilator Agents
• isosorbide-hydralazine combination
• Hydralazine
• Isosorbide Dinitrate

Topics

• Black or African American
• Clinical Trials as Topic (ethics)
• Drug Approval
• Drug Combinations
• Ethics, Medical
• Heart Failure (drug therapy, ethnology)
• Humans
• Hydralazine (therapeutic use)
• Isosorbide Dinitrate (therapeutic use)
• Male
• Prejudice
• Racial Groups (genetics)
• Syphilis (drug therapy, ethnology)
• Vasodilator Agents (therapeutic use)
• Withholding Treatment (ethics)